Cytogenetic Market: By Product (Consumables, Testing Kits, Media, and Reagents, Probes, Others (Affinity Reagents and Stains), Instruments, Software & Services), By Techniques (Comparative, Genomic Hybridization (CGH), Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, Others), By Application (Genetic Disorders, Cancer, Personalized Medicine, Others), By End User (Clinical & Research Laboratories, Pharmaceutical &, Biotechnology Companies, Academic Research Institutes, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Cytogenetics Market size is valued at USD 2.5 billion in 2023 and is poised to grow at a significant CAGR of 9.8% over 2024-2030. Bridging the gap between clinical applications of genetic results and offering an advanced medical service is the most crucial aim of human genetics. The adoption of cytogenetic techniques is directly impacted by the growth in the use of genetic information in predictive models for disease features, increasing income generation. The market has been considerably pushed by rising cancer mortality rates and the associated increase in cancer incidence. The ongoing increase in cancer cases has highlighted the requirement for creating cutting-edge technology for a thorough understanding of cancer at the genomic level.

Furthermore, the most well-known cytogenetic methods include FISH and CGH, which offer comprehensive details on the molecular signatures of cancer. These techniques help with gaining an understanding of how cancer develops. As several cytogenetic procedures have been effectively used for pharmacogenomic biomarker investigations, expanding pharmacogenomics activities are predicted to impact market growth significantly. A sizable number of published studies proving the function of cytogenetic methods in pharmacogenomic testing demonstrate the practical application of CGH, FISH, and sequencing technology in pharmacogenomics. The application range of cytogenetics techniques has been expanded due to ongoing improvements in CGH and FISH regarding resolution and specificity in basic research and molecular diagnostics. These developments have effectively overcome the limits of traditional cytogenetic analysis. Moreover, it is anticipated that the worldwide cytogenetics market will expand in the upcoming years due to an increase in healthcare spending, the prevalence of chronic diseases, and a favorable reimbursement environment. Additionally, market players use cutting-edge methods and tactics to develop original approaches to cytogenetic analysis, which is predicted to drive the market. However, emerging markets are anticipated to offer the industry excellent market possibilities during the projection period.

Cytogenetics Market Key Developments:
  • In March 2020, Agilent Technologies Inc. launched three new microarrays to meet the requirement of cytogenetics laboratories that conduct prenatal and postnatal research.

Cytogenetics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.8%

Largest Market

North America

Fastest Growing Market

North America
Cytogenetics Market Dynamics

As cancer cases increase, different molecular cytogenetics techniques are increasingly employed for diagnosis. Aside from that, the cytogenetics sector's development is fueled by the expansion of cancer research because cutting-edge methods are required to comprehend cancer at the chromosomal level. For instance, FISH and CGH procedures offer vital information on cancer-related molecular markers, leading to market development. FISH, chromosomal image analysis, flow sorting, and in-situ genomic hybridization (GISH), created to synthesize synthetic plant chromosomes, are used to develop genetic, physical, molecular, and comparative maps. However, the high price of cytogenetic tools restricts commercial expansion.

Cytogenetics Market Segmentation

By Product Type
  • Consumables
  • Testing Kits, Media, and Reagents
  • Probes
  • Others (Affinity Reagents and Stains)
  • Instruments
  • Software & Services
By Application
  • Genetic Disorders
  • Cancer
  • Personalized Medicine
  • Others
By End User
  • Clinical & Research Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Others

Frequently Asked Questions

The cytogenetic market is projected to expand at a CAGR of 9.8% during the forecast period.

Agilent Technologies, PerkinElmer, Inc., Illumina, Inc., Bio-Rad Laboratories, Oxford Gene Technology, Applied Spectral Imaging

North America is the fastest-growing region for cytogenetic market

Key Features of the Reports

  • The cytogenetic market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Cytogenetic Market Introduction 
2.1.Global Cytogenetic Market  - Taxonomy
2.2.Global Cytogenetic Market  - Definitions
2.2.1. By Product Type 
2.2.2. By Application
2.2.3. By End Users
2.2.4. By Region
3.Global Cytogenetic Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cytogenetic Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cytogenetic Market  By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Consumables
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Testing Kits, Media, and Reagents
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Probes
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others (Affinity Reagents and Stains)
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Instruments
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Software & Services
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Cytogenetic Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Genetic Disorders
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cancer
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Personalized Medicine
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Cytogenetic Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Clinical & Research Laboratories
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Academic Research Institutes
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Cytogenetic Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Cytogenetic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Consumables
9.1.2.Testing Kits, Media, and Reagents
9.1.3.Probes
9.1.4.Others (Affinity Reagents and Stains)
9.1.5.Instruments
9.1.6.Software & Services
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Genetic Disorders
9.2.2.Cancer
9.2.3.Personalized Medicine
9.2.4.Others
9.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Clinical & Research Laboratories
9.3.2.Pharmaceutical & Biotechnology Companies
9.3.3.Academic Research Institutes
9.3.4.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Cytogenetic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Consumables
10.1.2.Testing Kits, Media, and Reagents
10.1.3.Probes
10.1.4.Others (Affinity Reagents and Stains)
10.1.5.Instruments
10.1.6.Software & Services
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Genetic Disorders
10.2.2.Cancer
10.2.3.Personalized Medicine
10.2.4.Others
10.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Clinical & Research Laboratories
10.3.2.Pharmaceutical & Biotechnology Companies
10.3.3.Academic Research Institutes
10.3.4.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Cytogenetic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Consumables
11.1.2.Testing Kits, Media, and Reagents
11.1.3.Probes
11.1.4.Others (Affinity Reagents and Stains)
11.1.5.Instruments
11.1.6.Software & Services
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Genetic Disorders
11.2.2.Cancer
11.2.3.Personalized Medicine
11.2.4.Others
11.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Clinical & Research Laboratories
11.3.2.Pharmaceutical & Biotechnology Companies
11.3.3.Academic Research Institutes
11.3.4.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Cytogenetic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Consumables
12.1.2.Testing Kits, Media, and Reagents
12.1.3.Probes
12.1.4.Others (Affinity Reagents and Stains)
12.1.5.Instruments
12.1.6.Software & Services
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Genetic Disorders
12.2.2.Cancer
12.2.3.Personalized Medicine
12.2.4.Others
12.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Clinical & Research Laboratories
12.3.2.Pharmaceutical & Biotechnology Companies
12.3.3.Academic Research Institutes
12.3.4.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Cytogenetic Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Consumables
13.1.2.Testing Kits, Media, and Reagents
13.1.3.Probes
13.1.4.Others (Affinity Reagents and Stains)
13.1.5.Instruments
13.1.6.Software & Services
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Genetic Disorders
13.2.2.Cancer
13.2.3.Personalized Medicine
13.2.4.Others
13.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Clinical & Research Laboratories
13.3.2.Pharmaceutical & Biotechnology Companies
13.3.3.Academic Research Institutes
13.3.4.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Hoffmann-La Roche Ltd.
14.2.2.Danaher Corporation
14.2.3.Thermo Fisher Scientific, Inc.
14.2.4.Abbott Laboratories,
14.2.5.Agilent Technologies
14.2.6.PerkinElmer, Inc.
14.2.7.Bio-Rad Laboratories
14.2.8.Oxford Gene Technology
14.2.9.Applied Spectral Imaging
15. Research Methodology 
16. Appendix and Abbreviations 
  • Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories,
  • Agilent Technologies
  • PerkinElmer, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories
  • Oxford Gene Technology
  • Applied Spectral Imaging

Adjacent Markets